US IN

(888) 440-0954

EVENTS:

EASD 2017 will focus to draw attention towards the topics concerning diabetes and other related subjects. Researches taking place around the globe on clinical and experimental diabetes and metabolism will be discussed.

11September2017 - 15September2017

Feira Internacional de Lisboa, Lisbon, Portugal


http://easdcongress2017.org/

Dr. Narayanan has a special interest in the genetic basis of neurological disorders. In 2005, he began a clinical research artnership with TGen by establishing the CHC-BNI-TGen Pediatric Neurogenetics Center (Center for Excellence) at the Children’s Health Center, St. Joseph’s Hospital and Medical Center. In 2012 he became the Medical Director for TGen’s Center for Rare Childhood Disorders. The Center uses next generation sequencing to help diagnose children with neurological disorders of unknown genetic etiology.
In the summer of 2014 he moved his research lab to TGen. His research interests include the neurobiology of genetic disorders (genes to pathogenesis), cell adhesion molecules and synapse formation. Current projects deal with Rett syndrome, Tuberous Sclerosis Complex (TSC), Neurofibromatosis 1 (NF1) and other pediatric neurological disorders. He is the director of the Neurofibromatosis Planning Clinic and the Tuberous Sclerosis Clinic at CRS (Children’s Rehabilitative Services)

Seattle is one of the world’s centers of cancer immunotherapy. Three years ago, Xconomy gathered some of the field’s experts to talk about the promises of harnessing the immune system to fight cancer. Today, some of those promises seem well within reach, and a small but growing number of patients are benefiting from a handful of approved (and expensive) drugs. But while the opportunities seem closer at hand, many challenges remain. It’s time to gather again in Seattle to discuss what’s gone right, what’s gone wrong, and how the field’s brightest minds are working through the obstacles inherent when complicated biology, cutting-edge medical practice, and financial pressures meet.

14June2017

1:30 pm – 5:30 pm


Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, Seattle, WA 98109, United States.


http://www.xconomy.com/seattle/2017/03/01/xconomys-exome-presents-whats-hot-in-cancer-immunotherapy-2017/

The Scientific Sessions offers researchers and health care professionals the unique opportunity to share ideas and learn about the significant advances in diabetes research, treatment, and care. Over the course of five days, participants will receive exclusive access to more than 3,000 original research presentations, take part in provocative and engaging exchanges with leading diabetes experts and expand professional networks with over 13,000 professional attendees from around the world.

The ASCO Annual Meeting brings together more than 30,000 oncology professionals from around the world to discuss state-of-the-art treatment modalities, new therapies, and ongoing controversies in the field.

MedGenome is presenting its lead product OncoPept which addresses cancer immunotherapy at the event.

02June2017 - 06June2017

Chicago, Illinois


https://am.asco.org/

Cambridge Healthtech Institute’s Thirteenth Annual Biomarkers and Immuno-Oncology World Congress is our longest-running event dedicated to all areas of biomarker research and development spanning the pharmaceutical and diagnostic pipelines. With the promising developments in immuno-oncology over the past five years, much of the biomarker R&D has shifted to discovery and development of predictive biomarkers for immunotherapy patient stratification, understanding tumor mutational load and neoantigens in developing personalized immunotherapy approaches, using biomarker or mechanism data to choose rational combination immunotherapy, and applying immune profiling to predict response to immunotherapy. In response to the growing interest, we are increasing the coverage of immuno-oncology with four dedicated tracks.

The Biomarkers and Immuno-Oncology World Congress brings together a unique and international mix of large and medium pharmaceutical, biotech, diagnostics companies, leading universities, clinical research institutions, government and national labs, CROs, emerging companies and tool providers. Making the Congress a perfect meeting-place to share experience, foster collaborations across industry and academia, and evaluate emerging technologies.

02May2017 - 04May2017

Philadelphia, MA


http://www.biomarkerworldcongress.com

PEGS Summit will return to Boston May 1-5, 2017 for another inspiring  week-long event providing an exclusive platform for collaboration and discussion amongst a variety of academic and industry perspectives.

Network with world-class experts from pharma, academia, and government to share information, case studies, and best practices covering a vast area of biologic drug development and hear in-depth presentations on protein and antibody engineering, immunotherapy, oncology, expression, analytical, immunogenicity, and therapeutics.

01May2017 - 05May2017

Boston, MA


http://www.pegsummit.com/

Considering genomic research?

We’re at your service

*
 
*
*